Table 3.
The mean difference of the effect of Vitamin D versus placebo on symptoms severity score, irritable bowel syndrome-quality of life, and total score between the groups
Characteristic | Vitamin D group | Placebo group | Crude (P) | Adjusted (P) | ||
---|---|---|---|---|---|---|
Crude | Adjusted | Crude | Adjusted | |||
SSS (mean±SE)a | 60.23±12.67 | 61.46±14.54 | 34.45±13.76 | 35.55±13.54 | <0.05 | <0.05 |
IBS-QOL (mean±SE)a | 44.17±6.98 | 48.13±4.24 | 39.13±4.87 | 35.18±4.24 | 0.556 | 0.039* |
Total score (mean±SE)a | 66.52±5.35 | 66.69±4.08 | 26.30±3.30 | 26.14±4.08 | <0.001* | <0.001* |
Crude significances are based on independent t-test and adjusted significances are based on ANCOVA adjusting the effects of age, IBS-QOL baseline score, and baseline value of each factor as covariates, *Statistically significant, aOn week 6, bOn week 10. SSS=Symptoms severity score, QOL=Quality of life, SE=Standard error, IBS=Irritable bowel syndrome, ANCOVA=Analysis of covariance